These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Antihemophilic globulin consumption during blood coagulation. DOUGLAS AS Blood; 1956 May; 11(5):423-9. PubMed ID: 13315504 [No Abstract] [Full Text] [Related]
27. [Modification of coagulation factor IX by hydroxycoumarin and phenylindandione derivatives]. EGLI H; SCHNEIDER W Thromb Diath Haemorrh; 1961 Sep; 6():331-8. PubMed ID: 13889446 [No Abstract] [Full Text] [Related]
28. [Behavior of various factors of blood coagulation during anticoagulant therapy with MG 2555 in surgery]. VITTORIA G; CONDURSO R Rass Int Clin Ter; 1958 Feb; 38(3):97-104. PubMed ID: 13527706 [No Abstract] [Full Text] [Related]
29. Phenylindandione: a new oral anticoagulant. COON WW; DUFF IF; HODGSON PE; DENNIS EW Med Bull (Ann Arbor); 1953 Apr; 19(4):77-9. PubMed ID: 13049722 [No Abstract] [Full Text] [Related]
30. Clinical use of a new anticoagulant, phenylindanedione; report of 400 cases. BLAUSTEIN A; SHNAYERSON N; WALLACH R Am J Med; 1953 Jun; 14(6):704-6. PubMed ID: 13057880 [No Abstract] [Full Text] [Related]
31. [The viscocoagulography, a new device for objective registration of blood coagulation]. Zeschke G; Gnüchtel U Z Gesamte Inn Med; 1968 May; 23(10):297-305. PubMed ID: 5701144 [No Abstract] [Full Text] [Related]
32. The effect of two synthetic anticoagulant drugs (coumarin and inandione) in the ewe. Morag M; Smith DR Res Vet Sci; 1971 Mar; 12(2):106-12. PubMed ID: 5572531 [No Abstract] [Full Text] [Related]
33. A one stage method for the assay of antihemophilic factor B (AHF B) with a comment on the antihemophilic factor B (AHF B) concentration in phenylindanedione (PID) therapy. STAPP WF Scand J Clin Lab Invest; 1958; 10(2):169-76. PubMed ID: 13602673 [No Abstract] [Full Text] [Related]
34. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin. TAGER M Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268 [No Abstract] [Full Text] [Related]
35. MAO inhibitor and anticoagulant in shortening of prothrombin time by adrenaline, cholesterol and traumatization. SHIMAMOTO T; TAKEUCHI K; ISHIOKA T Chemotherapia (Basel); 1962; 4():227-36. PubMed ID: 13911936 [No Abstract] [Full Text] [Related]
37. Effect of diphacinone on blood coagulation in Spermophilus beecheyi as a basis for determining optimal timing of field bait applications. Whisson DA; Salmon TP Pest Manag Sci; 2002 Jul; 58(7):736-8. PubMed ID: 12146176 [TBL] [Abstract][Full Text] [Related]
38. LABORATORY CONTROL OF ANTICOAGULANT THERAPY. LAU KS; SINGH N Med J Malaya; 1963 Dec; 18():107-15. PubMed ID: 14117278 [No Abstract] [Full Text] [Related]
39. [The diagnostic capability of thrombelastogram, heparin and hirudin tolerance tests during anticoagulant therapy]. Fiedler H; Thiele G Z Arztl Fortbild (Jena); 1970 Jun; 64(12):600-2. PubMed ID: 5519345 [No Abstract] [Full Text] [Related]
40. Effect of anticoagulants on blood viscosity, circulation time and the capillaroscopic picture. Pavlovskii DP Fed Proc Transl Suppl; 1966; 25(2):367-9. PubMed ID: 4160513 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]